Clinical Lab preview
Immunovia is developing an in-house laboratory service offering clinical testing for early diagnosis of pancreatic cancer. Patient serum samples are analyzed on in-house produced Immunovia antibody microarrays. Each microarray generates protein expression profiles (molecular fingerprints) that are evaluated for pancreatic cancer using Immunovia’s classification software algorithm.
Our quality system meets the following general regulatory requirements:
EN ISO 13485
Application to SWEDAC for ISO/IEC 17025 accreditation is planned during 2018.